|
|
|
|
Logicden Launches Drug Medical Information (DMI) Software, Along with Search Request Manager (SRM) and Drug Literature Knowledgebase (DLK) for Pharmaceuticals
--(PR.com)-- Logicden proudly announces the launch of a software-suite for managing published literature in the life sciences at the 21st DIA Annual Workshop at the Medical Communications conference, sponsored by the Drug Information Association.This...
|
|
|
Fox Insurance Companys Drug Plan Terminated by Medicare
Welcome to the Ohio Department of Insurance Please Note: You are viewing the non-styled version of Ohio Department of Insurance.Either your browser does not support Cascading Style Sheets (CSS) or it is disabled. We suggest upgrading your browser to the...
|
|
|
Logicden Launches Drug Medical Information (DMI) Software, Along with Search Request Manager (SRM) and Drug Literature Knowledgebase (DLK) for Pharmaceuticals
--(PR.com)-- Logicden proudly announces the launch of a software-suite for managing published literature in the life sciences at the 21st DIA Annual Workshop at the Medical Communications conference, sponsored by the Drug Information Association.This...
|
|
|
Patient Advocacy Group asks FDA to Enhance its Enforcement of Unapproved Drugs Initiative
Agency encouraged to eliminate unapproved drugs that put patients at unnecessary risk WASHINGTON--(EON: Enhanced Online News)--The National Minority Quality Forum (The Forum) is launching a new public information campaign aimed to help educate consumers,...
|
|
|
FDA Approves NerPharMa to Manufacture Cell Therapeutics' Drug Pixantrone
Cell Therapeutics, Inc.('CTI') (Nasdaq and MTA: CTIC) today announced that the U.S. Food and Drug Administration ('FDA') has completed its inspection of the facility at NerPharMa (a pharmaceutical manufacturing company belonging to Nerviano Medical...
|
|
|
FDA Allows IND for Bio-Path Holdings Liposomal Grb-2
Company to Commence Phase I Clinical Trial of Its Cancer Drug Candidate to Treat CML, AML, ALL & MDS HOUSTON(BUSINESS WIRE) Bio-Path Holdings, Inc.(OTCBB: BPTH), a publicly traded biotechnology company with drug development operations in...
|
|
|
Drug patents worth $60bn to expire in 4 years [The Times of India]
12CHENNAI, India Nearly $60 billion worth of patents for drugs is set to expire in the next four years across the world and Indian pharmaceutical companies are now in a position to take a major share of this pie, industry members said.Already, India is...
|
|
|
Shruthi Bulk Drugs of Secunderabad booked for exporting ketamine without drug license
The Drugs Control Administration in Andhra Pradesh has registered a case under Section 18 (c) of Drugs and Cosmetics Act, 1940, against the Secunderabad-based Shruthi Bulk Drugs Pvt Ltd for purchasing, selling and exporting 3300 kg of Ketamine...
|
|
|
Files to notify Guidelines on Spurious Drugs Act stuck with Law Ministry
The Union Health Ministry's renewed efforts to notify the Guidelines attached to the newly amended Drugs and Cosmetics Act (better known as Spurious Drugs Act among the pharma parlance) is learnt to be stuck in the Union Law Ministry for some time....
|
|
|
Cancer Drugs May Not Cure Pfizer
The drug industry's big bet on expensive targeted cancer drugs may be starting to fail.In recent years, companies like Pfizer have put more targeted cancer drugs into trials than ever before. (See ) The drugs aim at one or more...
|
|
|
Cancer Drugs May Not Cure Pfizer
The drug industry's big bet on expensive targeted cancer drugs may be starting to fail.In recent years, companies like Pfizer have put more targeted cancer drugs into trials than ever before. The drugs aim at one or more defective...
|
|
|
Drug Development: New findings in drug development described from Pfizer Inc.
Today's Medical & Research News Drug Development New findings in drug development described from Pfizer Inc.March 12th, 2010 Printer-Friendly Version City:Groton State:CT Country:United States Drug Development Drug Discovery...
|
|
|
Shoppers Drug Mart Corporation to file 2009 audited financial statements and Management's Discussion and Analysis on SEDAR
TORONTO, March 11 /CNW/ - Shoppers Drug Mart Corporation (TSX: SC.TO) today announced that its audited financial statements and Management's Discussion and Analysis for its fiscal year ended January 2, 2010 have been filed with Canadian Securities...
|
|
|
Patient Advocacy Group asks FDA to Enhance its Enforcement of Unapproved Drugs Initiative
WASHINGTONThe National Minority Quality Forum (The Forum) is launching a new public information campaign aimed to help educate consumers, physicians, and policymakers about the risks associated with prescribing and taking unapproved drugs that have not...
|
|
|
No Cure For Pfizer From Cancer
The drug industry's big bet on expensive targeted cancer drugs may be starting to fail.In recent years, companies like Pfizer have put more targeted cancer drugs into trials than ever before. (See ) The drugs aim at one or more...
|
|
|
Patient Advocacy Group asks FDA to Enhance its Enforcement of Unapproved Drugs Initiative
The National Minority Quality Forum : (The Forum) is launching a new public information campaign aimed to help educate consumers, physicians, and policymakers about the risks associated with prescribing and taking unapproved drugs that have not been...
|
|
|
Patient Advocacy Group asks FDA to Enhance its Enforcement of Unapproved Drugs Initiative
Agency encouraged to eliminate unapproved drugs that put patients at unnecessary risk WASHINGTON--(BUSINESS WIRE)-- The National Minority Quality Forum (The Forum) is launching a new public information campaign aimed to help educate consumers, physicians,...
|
|
|
Patient Advocacy Group asks FDA to Enhance its Enforcement of Unapproved Drugs Initiative
Agency encouraged to eliminate unapproved drugs that put patients at unnecessary risk WASHINGTON--(BUSINESS WIRE)-- The National Minority Quality Forum (The Forum) is launching a new public information campaign aimed to help educate consumers, physicians,...
|
|
|
Patient Advocacy Group asks FDA to Enhance its Enforcement of Unapproved Drugs Initiative
Minority Quality Forum (The Forum) is launching a new public information campaign aimed to help educate consumers, physicians, and policymakers about the risks associated with prescribing and taking unapproved drugs that have not been subjected to the...
|
|
|
Patient Advocacy Group asks FDA to Enhance its Enforcement of Unapproved Drugs Initiative
Agency encouraged to eliminate unapproved drugs that put patients at unnecessary risk The National Minority Quality Forum (The Forum) is launching a new public information campaign aimed to help educate consumers, physicians, and policymakers about the...
|
|
|
Patient Advocacy Group asks FDA to Enhance its Enforcement of Unapproved Drugs Initiative
WASHINGTON - (Business Wire) The (The Forum) is launching a new public information campaign aimed to help educate consumers, physicians, and policymakers about the risks associated with prescribing and taking unapproved drugs that have not been subjected...
|
|
|
Clinical Trial Research: New clinical trial research study findings recently were reported by researchers at Pfizer Inc.
Today's Medical & Research News New study findings recently were reported by researchers at Pfizer Inc.March 12th, 2010 Printer-Friendly Version City:St Louis State:MO Country:United States Drug Development Drug Discovery Drugs Kidney...
|
|
|
Drug-drug interactions common with methotrexate or cyclosporine for psoriasis
MedWire News: Researchers warn of the potential risk for drug-drug interactions in patients prescribed methotrexate or cyclosporine for psoriasis, and the substantial impact of these interactions on healthcare resources.They report that over half...
|
|
|
InterMune's IPF Drug Closer to FDA Approval
The US Food and Drug Administrations Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted 9 to 3 to recommend approval of InterMune's Esbriet (pirfenidone) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline...
|
|
|
Patient Advocacy Group asks FDA to Enhance its Enforcement of Unapproved Drugs Initiative
Patient Advocacy Group asks FDA to Enhance its Enforcement of Agency encouraged to eliminate unapproved drugs that put patients at unnecessary risk WASHINGTON--(BUSINESS WIRE)--The (The Forum) is launching a new public information campaign aimed to help...
|
